Litcius/Paper detail

Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway

Qinhai Ma, Runfeng Li, Weiqi Pan, Wenbo Huang, Bin Liu, Yuqi Xie, Zhoulang Wang, Chufang Li, Haiming Jiang, Jicheng Huang, Yongxia Shi, Jun Dai, Kui Zheng, Xiaobo Li, Hui Min, Li Fu, Zifeng Yang

2020Phytomedicine112 citationsDOIOpen Access PDF

Topics & Concepts

Proinflammatory cytokineCoronavirusWestern blotVero cellVirologyTumor necrosis factor alphaNF-κBNFKB1CytokineImmune systemIn vitroBiologyChemistryMicrobiologyImmunologyInflammationVirusMedicineCoronavirus disease 2019 (COVID-19)BiochemistryGeneDiseasePathologyInfectious disease (medical specialty)Transcription factorPhytochemistry and Biological ActivitiesComputational Drug Discovery MethodsPhytochemicals and Medicinal Plants
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway | Litcius